Ligne de temps
Nicole Prada
Chef(fe) de Projet
02 juil. 2015
25 mai 2015
15 avr. 2015
publication
Viral envelope is a major determinant of enhanced fitness of a multidrug-resistant HIV-1 variant
Lire plus15 avr. 2015
11 mars 2015
publication
Antitumor immunity triggered by melphalan is potentiated by melanoma cell surface-associated calreticulin
Lire plus01 janv. 2015
publication
Combined evaluation of LC3B puncta and HMGB1 expression predicts residual risk of relapse after adjuvant chemotherapy in breast cancer
Lire plus01 juin 2014
publication
A randomized open-label study of 3- versus 5-drug combination antiretroviral therapy in newly HIV-1-infected individuals
Lire plus28 juin 2013
publication
Defective immunogenic cell death of HMGB1-deficient tumors: compensatory therapy with TLR4 agonists
Lire plus13 juin 2013
01 mars 2013
publication
Analysis of NKp30/NCR3 isoforms in untreated HIV-1-infected patients from the ANRS SEROCO cohort
Lire plus01 sept. 2010
03 août 2009
publication
Natural polymorphisms of human immunodeficiency virus type 1 integrase and inherent susceptibilities to a panel of integrase inhibitors
Lire plus01 oct. 2008
publication
Drug-susceptible HIV-1 infection despite intermittent fixed-dose combination tenofovir/emtricitabine as prophylaxis is associated with low-level viremia, delayed seroconversion, and an attenuated clinical course
Lire plus01 juin 2008
publication
Homeostatic cytokines and expansion of regulatory T cells accompany thymic impairment in children with Down syndrome
Lire plus17 janv. 2007
publication
Mitochondrial alterations and tendency to apoptosis in peripheral blood cells from children with Down syndrome
Lire plus01 nov. 2005
publication
Characterization of cells with different mitochondrial membrane potential during apoptosis
Lire plus01 oct. 2005
publication
MMP-7 promoter polymorphisms do not influence CD4+ recovery and changes in plasma viral load during antiretroviral therapy for HIV-1 infection
Lire plus16 févr. 2005
01 janv. 2005
publication